WallStreetZenWallStreetZen

NASDAQ: INSM
Insmed Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

INSM past revenue growth

How has INSM's revenue growth performed historically?
Company
15.95%
Industry
110.58%
Market
14.02%
INSM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INSM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INSM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INSM earnings and revenue history

Current Revenue
$280.8M
Current Earnings
-$723.6M
Current Profit Margin
-257.7%

INSM Return on Equity

Current Company
N/A
Current Industry
15.6%
Current Market
-8.4%

Be the first to know when INSM announces earnings.

INSM Return on Assets

Current Company
-48.7%
Current Industry
2.2%
INSM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INSM Return on Capital Employed

Current Company
-57.14%
Current Industry
17.7%
INSM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INSM vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INSM$280.82M-$624.35M-$723.63M+29.26%N/A
MRTX$38.19M-$721.44M-$725.88M+32.18%N/A
MDGL$0.00-$336.40M-$347.34MN/AN/A
NUVL$0.00-$114.05M-$114.05MN/AN/A
BPMC$216.20M-$503.85M-$554.71M+36.81%N/A
View Top Biotech Stocks

Insmed Earnings & Revenue FAQ

What were INSM's earnings last quarter?

On Invalid Date, Insmed (NASDAQ: INSM) reported Q3 2023 earnings per share (EPS) of -$1.11, up 1.83% year over year. Total Insmed earnings for the quarter were -$158.93 million. In the same quarter last year, Insmed's earnings per share (EPS) was -$1.09.

If you're new to stock investing, here's how to buy Insmed stock.

What was INSM's earnings growth in the past year?

As of Q4 2023, Insmed's earnings has grown year over year. Insmed's earnings in the past year totalled -$723.63 million.

What was INSM's revenue last quarter?

On Invalid Date, Insmed (NASDAQ: INSM) reported Q3 2023 revenue of $79.07 million up 16.75% year over year. In the same quarter last year, Insmed's revenue was $67.73 million.

What was INSM's revenue growth in the past year?

As of Q4 2023, Insmed's revenue has grown 15.95% year over year. This is 94.62 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Insmed's revenue in the past year totalled $280.82 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.